Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Disease Models, Animal »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Disease Management < Disease Models, Animal < Disease Outbreaks  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 139.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000014 (1999) K S Topp [États-Unis] ; N N BylMovement dysfunction following repetitive hand opening and closing: anatomical analysis in Owl monkeys.
000075 (1999) H. Wilms [Allemagne] ; J. Sievers ; G. DeuschlAnimal models of tremor.
000081 (1999) E. Grünblatt [Israël] ; S. Mandel ; T. Berkuzki ; M B YoudimApomorphine protects against MPTP-induced neurotoxicity in mice.
000117 (1999) B. Henry [Royaume-Uni] ; S H Fox ; D. Peggs ; A R Crossman ; J M BrotchieThe alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.
000205 (2000) W G Ondo [États-Unis] ; Y. He ; S. Rajasekaran ; W D LeClinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.
000255 (2000) M. Hallett [États-Unis]Physiology of human posthypoxic myoclonus.
000257 (2000) B Q Nguyen [États-Unis] ; A G Kanthasamy ; D D TruongAnimal models of myoclonus: an overview.
000258 (2000) D D Truong [États-Unis] ; A. Kanthasamy ; B. Nguyen ; R. Matsumoto ; P. SchwartzAnimal models of posthypoxic myoclonus: I. Development and validation.
000259 (2000) A G Kanthasamy [États-Unis] ; B Q Nguyen ; D D TruongAnimal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization.
000279 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000328 (2000) M. Rodríguez [Espagne] ; P. Abdala ; J A ObesoExcitatory responses in the 'direct' striatonigral pathway: effect of nigrostriatal lesion.
000347 (2000) R J Carter [Royaume-Uni] ; M J Hunt ; A J MortonEnvironmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene.
000454 (2001) A. Handforth [États-Unis] ; S E KrahlSuppression of harmaline-induced tremor in rats by vagus nerve stimulation.
000458 (2001) H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C HirschCaspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000499 (2001) K P Datla [Royaume-Uni] ; S B Blunt ; D T DexterChronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
000577 (2001) M. Pandolfo [Canada]Molecular basis of Friedreich ataxia.
000580 (2001) R E Yee [États-Unis] ; I. Irwin ; C. Milonas ; D B Stout ; S C Huang ; K. Shoghi-Jadid ; N. Satyamurthy ; L E Delanney ; D M Togasaki ; K F Farahani ; K. Delfani ; A M Janson ; M E Phelps ; J W Langston ; J R BarrioNovel observations with FDOPA-PET imaging after early nigrostriatal damage.
000647 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000707 (2002) Alfredo Berardelli [Italie] ; Antonio CurraPathophysiology and treatment of cranial dystonia.
000755 (2002) Hagai Bergman [Israël] ; Günther DeuschlPathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back.
000946 (2002) Mikko Kuoppam Ki [Royaume-Uni] ; Ghassan Al-Barghouthy ; Michael Jackson ; Lance Smith ; Bai-Yun Zeng ; Niall Quinn ; Peter JennerBeginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Disease Models, Animal" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Disease Models, Animal" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Disease Models, Animal
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024